Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24


CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds.

Yankelevitz DF, Yip R, Smith JP, Liang M, Liu Y, Xu DM, Salvatore MM, Wolf AS, Flores RM, Henschke CI; International Early Lung Cancer Action Program Investigators Group..

Radiology. 2015 Nov;277(2):555-64. doi: 10.1148/radiol.2015142554. Epub 2015 Jun 23.


CT screening for lung cancer: Importance of emphysema for never smokers and smokers.

Henschke CI, Yip R, Boffetta P, Markowitz S, Miller A, Hanaoka T, Wu N, Zulueta JJ, Yankelevitz DF; I-ELCAP Investigators..

Lung Cancer. 2015 Apr;88(1):42-7. doi: 10.1016/j.lungcan.2015.01.014. Epub 2015 Feb 4.


Retrospective review of lung cancers diagnosed in annual rounds of CT screening.

Xu DM, Yip R, Smith JP, Yankelevitz DF, Henschke CI; I-ELCAP Investigators..

AJR Am J Roentgenol. 2014 Nov;203(5):965-72. doi: 10.2214/AJR.13.12115. Epub 2014 Sep 23. Review.


The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST.

Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP; International Early Lung Cancer Investigators..

Eur J Cancer Prev. 2015 May;24(3):201-8. doi: 10.1097/CEJ.0000000000000065.


Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer.

Flores R, Bauer T, Aye R, Andaz S, Kohman L, Sheppard B, Mayfield W, Thurer R, Smith M, Korst R, Straznicka M, Grannis F, Pass H, Connery C, Yip R, Smith JP, Yankelevitz D, Henschke C, Altorki N; I-ELCAP Investigators..

J Thorac Cardiovasc Surg. 2014 May;147(5):1619-26. doi: 10.1016/j.jtcvs.2013.11.001. Epub 2013 Dec 9.


Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.

Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, Sheppard B, Thurer R, Andaz S, Smith M, Mayfield W, Grannis F, Korst R, Pass H, Straznicka M, Flores R, Henschke CI; I-ELCAP Investigators..

J Thorac Cardiovasc Surg. 2014 Feb;147(2):754-62; Discussion 762-4. doi: 10.1016/j.jtcvs.2013.09.065. Epub 2013 Nov 23.


Definition of a positive test result in computed tomography screening for lung cancer: a cohort study.

Henschke CI, Yip R, Yankelevitz DF, Smith JP; International Early Lung Cancer Action Program Investigators*..

Ann Intern Med. 2013 Feb 19;158(4):246-52. doi: 10.7326/0003-4819-158-4-201302190-00004.


Lung cancers diagnosed at annual CT screening: volume doubling times.

Henschke CI, Yankelevitz DF, Yip R, Reeves AP, Farooqi A, Xu D, Smith JP, Libby DM, Pasmantier MW, Miettinen OS; Writing Committee for the I-ELCAP Investigators..

Radiology. 2012 May;263(2):578-83. doi: 10.1148/radiol.12102489. Epub 2012 Mar 27. Erratum in: Radiology. 2012 Jul;264(1):306.


CT- and computer-based features of small hamartomas.

Huang Y, Xu Dm, Jirapatnakul A, Reeves AP, Farooqi A, Zhang Lj, Giunta S, Zulueta J, Aye R, Miller A, Mendelson DS, Aylesworth C, Sheppard B, Klingler K, Yankelevitz DF, Henschke CI.

Clin Imaging. 2011 Mar-Apr;35(2):116-22. doi: 10.1016/j.clinimag.2010.02.011.


A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors.

Dees EC, Baker SD, O'Reilly S, Rudek MA, Davidson SB, Aylesworth C, Elza-Brown K, Carducci MA, Donehower RC.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):664-71. No abstract available.


Maintaining iron balance in women blood donors of childbearing age: summary of a workshop.

Bianco C, Brittenham G, Gilcher RO, Gordeuk VR, Kushner JP, Sayers M, Chambers L, Counts RB, Aylesworth C, Nemo G, Alving B.

Transfusion. 2002 Jun;42(6):798-805. No abstract available.


Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.

Tolcher AW, Eckhardt SG, Kuhn J, Hammond L, Weiss G, Rizzo J, Aylesworth C, Hidalgo M, Patnaik A, Schwartz G, Felton S, Campbell E, Rowinsky EK.

J Clin Oncol. 2001 Jun 1;19(11):2937-47.


Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel.

Hidalgo M, Aylesworth C, Hammond LA, Britten CD, Weiss G, Stephenson J Jr, Schwartz G, Patnaik A, Smith L, Molpus K, Felton S, Gupta E, Ferrante KJ, Tortora A, Sonnichsen DS, Skillings J, Rowinsky EK.

J Clin Oncol. 2001 May 1;19(9):2493-503.


A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors.

Tolcher AW, Aylesworth C, Rizzo J, Izbicka E, Campbell E, Kuhn J, Weiss G, Von Hoff DD, Rowinsky EK.

Ann Oncol. 2000 Mar;11(3):333-8.


Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.

Rowinsky EK, Humphrey R, Hammond LA, Aylesworth C, Smetzer L, Hidalgo M, Morrow M, Smith L, Garner A, Sorensen JM, Von Hoff DD, Eckhardt SG.

J Clin Oncol. 2000 Jan;18(1):178-86.


A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies.

Petit T, Aylesworth C, Burris H, Ravdin P, Rodriguez G, Smith L, Peacock N, Smetzer L, Bellet R, Von Hoff DD, Rowinsky EK.

Ann Oncol. 1999 Feb;10(2):223-9.


Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.

Rothenberg ML, Sharma A, Weiss GR, Villalona-Calero MA, Eckardt JR, Aylesworth C, Kraynak MA, Rinaldi DA, Rodriguez GI, Burris HA 3rd, Eckhardt SG, Stephens CD, Forral K, Nicol SJ, Von Hoff DD.

Ann Oncol. 1998 Jul;9(7):733-8.


Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

Rowinsky EK, Smith L, Wang YM, Chaturvedi P, Villalona M, Campbell E, Aylesworth C, Eckhardt SG, Hammond L, Kraynak M, Drengler R, Stephenson J Jr, Harding MW, Von Hoff DD.

J Clin Oncol. 1998 Sep;16(9):2964-76.


Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies.

Villalona-Calero MA, Baker SD, Hammond L, Aylesworth C, Eckhardt SG, Kraynak M, Fram R, Fischkoff S, Velagapudi R, Toppmeyer D, Razvillas B, Jakimowicz K, Von Hoff DD, Rowinsky E.

J Clin Oncol. 1998 Aug;16(8):2770-9.


Docetaxel in combination with fluorouracil: study design and preliminary results.

Rowinsky E, Smith L, Rodriguez G, White L, Drengler R, Von Hoff D, Peacock N, Aylesworth C, Burris H, Ravdin P, Bellet R.

Oncology (Williston Park). 1997 Jun;11(6 Suppl 6):33-5.

Supplemental Content

Loading ...
Support Center